Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer. Issue 2 (15th December 2019)
- Record Type:
- Journal Article
- Title:
- Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer. Issue 2 (15th December 2019)
- Main Title:
- Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer
- Authors:
- Hokari, Satoshi
Tamura, Yusuke
Kaneda, Atsushi
Katsura, Akihiro
Morikawa, Masato
Murai, Fumihiko
Ehata, Shogo
Tsutsumi, Shuichi
Ishikawa, Yuichi
Aburatani, Hiroyuki
Kikuchi, Toshiaki
Miyazono, Kohei
Koinuma, Daizo - Abstract:
- Abstract : Thyroid transcription factor‐1 (TTF‐1, encoded by the NKX2‐1 gene) is highly expressed in small‐cell lung carcinoma (SCLC) and lung adenocarcinoma (LADC), but how its functional roles differ between SCLC and LADC remains to be elucidated. Here, we compared the genome‐wide distributions of TTF‐1 binding regions and the transcriptional programs regulated by TTF‐1 between NCI‐H209 (H209), a human SCLC cell line, and NCI‐H441 (H441), a human LADC cell line, using chromatin immunoprecipitation‐sequencing (ChIP‐seq) and RNA‐sequencing (RNA‐seq). TTF‐1 binding regions in H209 and H441 cells differed by 75.0% and E‐box motifs were highly enriched exclusively in the TTF‐1 binding regions of H209 cells. Transcriptome profiling revealed that TTF‐1 is involved in neuroendocrine differentiation in H209 cells. We report that TTF‐1 and achaete‐scute homolog 1 (ASCL1, also known as ASH1, an E‐box binding basic helix–loop–helix transcription factor, and a lineage‐survival oncogene of SCLC) are coexpressed and bound to adjacent sites on target genes expressed in SCLC, and cooperatively regulate transcription. Furthermore, TTF‐1 regulated expression of the Bcl‐2 gene family and showed antiapoptotic function in SCLC. Our findings suggest that TTF‐1 promotes SCLC growth and contributes to neuroendocrine and antiapoptotic gene expression by partly coordinating with ASCL1. Abstract : A remarkable difference in the thyroid transcription factor‐1 (TTF‐1) binding regions on the genome wasAbstract : Thyroid transcription factor‐1 (TTF‐1, encoded by the NKX2‐1 gene) is highly expressed in small‐cell lung carcinoma (SCLC) and lung adenocarcinoma (LADC), but how its functional roles differ between SCLC and LADC remains to be elucidated. Here, we compared the genome‐wide distributions of TTF‐1 binding regions and the transcriptional programs regulated by TTF‐1 between NCI‐H209 (H209), a human SCLC cell line, and NCI‐H441 (H441), a human LADC cell line, using chromatin immunoprecipitation‐sequencing (ChIP‐seq) and RNA‐sequencing (RNA‐seq). TTF‐1 binding regions in H209 and H441 cells differed by 75.0% and E‐box motifs were highly enriched exclusively in the TTF‐1 binding regions of H209 cells. Transcriptome profiling revealed that TTF‐1 is involved in neuroendocrine differentiation in H209 cells. We report that TTF‐1 and achaete‐scute homolog 1 (ASCL1, also known as ASH1, an E‐box binding basic helix–loop–helix transcription factor, and a lineage‐survival oncogene of SCLC) are coexpressed and bound to adjacent sites on target genes expressed in SCLC, and cooperatively regulate transcription. Furthermore, TTF‐1 regulated expression of the Bcl‐2 gene family and showed antiapoptotic function in SCLC. Our findings suggest that TTF‐1 promotes SCLC growth and contributes to neuroendocrine and antiapoptotic gene expression by partly coordinating with ASCL1. Abstract : A remarkable difference in the thyroid transcription factor‐1 (TTF‐1) binding regions on the genome was identified between lung adenocarcinoma (LDAC) and small‐cell lung carcinoma (SCLC). TTF‐1 inhibits epithelial‐mesenchymal transition in LADC cells, while TTF‐1 cooperates with ASCL1 to induce neuroendocrine differentiation and antiapoptotic function in SCLC cells. … (more)
- Is Part Of:
- Molecular oncology. Volume 14:Issue 2(2020)
- Journal:
- Molecular oncology
- Issue:
- Volume 14:Issue 2(2020)
- Issue Display:
- Volume 14, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 14
- Issue:
- 2
- Issue Sort Value:
- 2020-0014-0002-0000
- Page Start:
- 277
- Page End:
- 293
- Publication Date:
- 2019-12-15
- Subjects:
- ASCL1 -- ChIP‐seq -- lung cancer -- NKX2‐1 -- SCLC -- TTF‐1
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.12608 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22426.xml